Picture of Diagonal Bio AB logo

DIABIO Diagonal Bio AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Diagonal Bio Announces That It Is Exploring Financing Options

Nov 11 (Reuters) - Diagonal Bio AB  DIABIO.ST :
    * ANNOUNCES THAT IT IS EXPLORING FINANCING OPTIONS
    * IS IN DISCUSSIONS WITH STRATEGIC INVESTORS AND SEVERAL OF
ITS
LARGER SHAREHOLDERS REGARDING POSSIBLE SOLUTIONS TO ADDRESS
COMPANY'S LIQUIDITY SITUATION
    * CO HAS PLAN, AMBITION TO REACH MARKET VALIDATION WITH
LAMPLIFY
IN 2025, FUNDS NEEDED FOR THIS OBJECTIVE IS ESTIMATED TO ABOUT
SEK 7 MILLION

Source text:  ID:nWkrbrf84B 
Further company coverage:  DIABIO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on Diagonal Bio AB

See all news